CRP and rheumatoid arthritis: While bone resorption was the primary focus of these comparative studies, also of clinical interest were metabolite effects on inflammation-driven vascular endothelial activation and elevated CRP levels in the RA model, both of which are risk factors for cardiovascular (CV) disease [46,63], which occurs more frequently in individuals with RA [64].